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BACKGROUND: Multiple endocrine neoplasia type 2B is a rare syndrome caused
mainly by Met918Thr germline RET mutation, and characterised by medullary thyroid
carcinoma, phaeochromocytoma, and extra-endocrine features. Data are scarce on
the natural history of multiple endocrine neoplasia type 2B. We aimed to advance
understanding of the phenotype and natural history of multiple endocrine neoplasia
type 2B, to increase awareness and improve detection.
METHODS: This study was a retrospective, multicentre, international study in
patients carrying the Met918Thr RET variant with no age restrictions. The study was
done with registry data from 48 centres globally. Data from patients followed-up from
1970 to 2016 were retrieved from May 1, 2016, to May 31, 2018. Our primary
objectives were to determine overall survival, and medullary thyroid carcinoma-
specific survival based on whether the patient had undergone early thyroidectomy
before the age of 1 year. We also assessed remission of medullary thyroid carcinoma,
incidence and treatment of phaeochromocytoma, and the penetrance of extra-
endocrine features.
FINDINGS: 345 patients were included, of whom 338 (98%) had a thyroidectomy. 71
patients (21%) of the total cohort died at a median age of 25 years (range <1-59).
Thyroidectomy was done before the age of 1 year in 20 patients, which led to long-
term remission (ie, undetectable calcitonin level) in 15 (83%) of 18 individuals (2
patients died of causes unrelated to medullary thyroid carcinoma). Medullary thyroid
carcinoma-specific survival curves did not show any significant difference between
patients who had thyroidectomy before or after 1 year (comparison of survival curves
by log-rank test: p=0·2; hazard ratio 0·35; 95% CI 0.07-1.74). However, there was a
significant difference in remission status between patients who underwent
thyroidectomy before and after the age of 1 year (p<0·0001). There was a significant
difference in remission status between patients who underwent thyroidectomy before
and after the age of 1 year (p<0·0001). In the other 318 patients who underwent
thyroidectomy after 1 year of age, biochemical and structural remission was obtained
in 47 (15%) of 318 individuals. Bilateral phaeochromocytoma was diagnosed in 156
(50%) of 313 patients by 28 years of age. Adrenal-sparing surgery was done in 31
patients: three (10%) of 31 patients had long-term recurrence, while normal adrenal
function was obtained in 16 (62%) patients. All patients with available data (n=287)
had at least one extra-endocrine feature, including 106 (56%) of 190 patients showing
marfanoid body habitus, mucosal neuromas, and gastrointestinal signs.
INTERPRETATION: Thyroidectomy done at no later than 1 year of age is associated
with a high probability of cure. The reality is that the majority of children with the
syndrome will be diagnosed after this recommended age. Adrenal-sparing surgery is
feasible in multiple endocrine neoplasia type 2B and affords a good chance for normal
adrenal function. To improve the prognosis of such patients, it is imperative that
every health-care provider be aware of the extra-endocrine signs and the natural
history of this rare syndrome. The implications of this research include increasing
awareness of the extra-endocrine symptoms and also recommendations for
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